References
- Cancer in Norway 2016 – Cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, 2017. Oslo: Cancer Registry of Norway; 2017.
- Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425–1437.
- Kyrdalen AE, Dahl AA, Hernes E, et al. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis. 2010;13:144–150.
- Tosoian JJ, Carter HB, Lepor A, et al. Active surveillance for prostate cancer: current evidence and contemporary state of practice. Nat Rev Urol. 2016;13:205–215.
- Spelten ER, Sprangers MAG, Verbeek J. Factors reported to influence the return to work of cancer survivors: a literature review. Psycho-oncology. 2002;11:124–131.
- Carlsen K, Oksbjerg Dalton S, Frederiksen K, et al. Cancer and the risk for taking early retirement pension: a Danish cohort study. Scand J Public Health. 2008;36:117–125.
- Ullrich A, Rath HM, Otto U, et al. Return to work in prostate cancer survivors – findings from a prospective study on occupational reintegration following a cancer rehabilitation program. BMC Cancer. 2018;18:751.
- Dahl S, Steinsvik EA, Dahl AA, et al. Return to work and sick leave after radical prostatectomy: a prospective clinical study. Acta Oncologica (Stockholm, Sweden. 2014;53:744–751.
- Dahl S, Loge JH, Berge V, et al. Influence of radical prostatectomy for prostate cancer on work status and working life 3 years after surgery. J Cancer Surviv. 2015;9:172–179.
- Bennett D, Kearney T, Donnelly DW, et al. Factors influencing job loss and early retirement in working men with prostate cancer-findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study. J Cancer Surviv. 2018;12:669–678.
- Gould R, Ilmarinen J, Järvisalo J. Dimensions of work ability Helsinki: Finnish Center for Pensions. 2008. Available from: https://sivusto.kykyviisari.fi/wp-content/uploads/2018/09/Gould-Dimensions-of-work-ability.pdf
- von Bonsdorff ME, Rantanen T, Tormakangas T, et al. Midlife work ability and mobility limitation in old age among non-disability and disability retirees–a prospective study. BMC Public Health. 2016;16;16:154.
- Dahl S, Cvancarova M, Dahl AA, et al. Work ability in prostate cancer survivors after radical prostatectomy. Scand J Urol. 2016;50:116–122.
- Ahlstrom L, Grimby-Ekman A, Hagberg M, et al. The work ability index and single-item question: associations with sick leave, symptoms, and health–a prospective study of women on long-term sick leave. Scand J Work Environ Health. 2010;36:404–412.
- Tuomi K,J, Jahkola A, Katajarinne L, 2nd Edition, et al. Work Ability Index. Helsinki: Finnish Institute for Occupational Health; 1998.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
- Szymanski KM, Wei JT, Dunn RL, et al. Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology. 2010;76:1245–1250.
- Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–153.
- Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45:53–65.
- Strand BH, Dalgard OS, Tambs K, et al. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry. 2003;57:113–118.
- Tambs K, Moum T. How well can a few questionnaire items indicate anxiety and depression? Acta Psychiatr Scand. 1993;87:364–367.
- EuroQol–a new facility for the measurement of health-related quality of life. Health policy. 1990;16:199–208.
- Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97.
- Thewes B, Zachariae R, Christensen S, et al. The Concerns About Recurrence Questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68–79.
- Langhammer A, Bratberg G, Heggland J, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol. 2013;42:968–977.
- Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology. 2017;71:618–629.
- Sloan JA, Vargas-Chanes D, Kamath C, et al. Detecting worms, ducks, and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. J Cancer Integr Med. 2003;1:41–47.
- Statistics Norway, Table 06161: Employed persons, by place of residence, sex and one-year age groups (per cent). 4th quarter 2017. 2017 [updated 2019 Feb 25]. Available from: www.ssb.no
- Taskila T, Martikainen R, Hietanen P, et al. Comparative study of work ability between cancer survivors and their referents. Eur J Cancer. 2007;43:914–920.
- Spelten ER, Verbeek J, Uitterhoeve ALJ, et al. Cancer, fatigue and the return of patients to work—a prospective cohort study. Eur J Cancer. 2003;39:1562–1567.